As a downstream effect of promoting Ikaros and Aiolos degradation, CELMoDs have been shown to downregulate the expression of CDC28 protein kinase regulatory subunit 1B (CKS1B), which is associated with poor prognosis in MM through its role in chromosome 1q amplification [72]. The gene discussed is IKZF3; the disease is Miyoshi myopathy.